146 related articles for article (PubMed ID: 63318)
21. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
22. Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases.
Nazeer T; Ro JY; Amato RJ; Park YW; Ordonez NG; Ayala AG
Oncol Rep; 1998; 5(6):1425-9. PubMed ID: 9769381
[TBL] [Abstract][Full Text] [Related]
23. Malignant ovarian tumors in children and adolescents.
Raney RB; Sinclair L; Uri A; Schnaufer L; Cooper A; Littman P
Cancer; 1987 Mar; 59(6):1214-20. PubMed ID: 3815296
[TBL] [Abstract][Full Text] [Related]
24. Treatment of malignant germ cell tumors of the ovary.
Chang FH; Lai CH; Chu KK; Chang TC; Hsueh S; Hung IJ
J Formos Med Assoc; 1994 May; 93(5):411-6. PubMed ID: 7920081
[TBL] [Abstract][Full Text] [Related]
25. Gonadoblastoma with dysgerminoma in one ovary and gonadoblastoma with dysgerminoma and yolk sac tumor in the contralateral ovary in a girl with 46XX karyotype.
Obata NH; Nakashima N; Kawai M; Kikkawa F; Mamba S; Tomoda Y
Gynecol Oncol; 1995 Jul; 58(1):124-8. PubMed ID: 7789879
[TBL] [Abstract][Full Text] [Related]
26. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
Mann JR; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendszus KR
Cancer; 1989 May; 63(9):1657-67. PubMed ID: 2467734
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
de la Motte Rouge T; Pautier P; Genestie C; Rey A; Gouy S; Leary A; Haie-Meder C; Kerbrat P; Culine S; Fizazi K; Lhommé C
Gynecol Oncol; 2016 Sep; 142(3):452-7. PubMed ID: 27401840
[TBL] [Abstract][Full Text] [Related]
28. [Malignant ovarian tumors in childhood].
Zucker JM
Bull Cancer; 1982; 69(3):304-13. PubMed ID: 6181838
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of histopathological subtypes in stage I pure yolk sac tumour of the ovary.
Sasaki H; Furusato M; Teshima S; Kiyokawa T; Tada A; Aizawa S; Yamabe T; Tsugane S; Terashima Y
Br J Cancer; 1994 Mar; 69(3):529-36. PubMed ID: 7510118
[TBL] [Abstract][Full Text] [Related]
30. Alpha fetoprotein determinations in the management of endodermal sinus tumors and mixed germ cell tumors of the ovary.
Romero R; Schwartz PE
Am J Obstet Gynecol; 1981 Sep; 141(2):126-31. PubMed ID: 6169279
[No Abstract] [Full Text] [Related]
31. Immature teratoma of the ovary.
Gallion H; van Nagell JR; Donaldson ES; Hanson MB; Powell DF
Am J Obstet Gynecol; 1983 Jun; 146(4):361-5. PubMed ID: 6190400
[TBL] [Abstract][Full Text] [Related]
32. Germ cell tumors of the ovary.
Kurman RJ; Norris HJ
Pathol Annu; 1978; 13 Pt 1():291-325. PubMed ID: 82930
[No Abstract] [Full Text] [Related]
33. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases.
Norris HJ; Zirkin HJ; Benson WL
Cancer; 1976 May; 37(5):2359-72. PubMed ID: 1260722
[TBL] [Abstract][Full Text] [Related]
34. Treatment of malignant ovarian germ cell tumors: response to vincristine, dactinomycin, and cyclophosphamide (preliminary report).
Slayton RE; Hreshchyshyn MM; Silverberg SC; Shingleton HM; Park RC; DiSalia PJ; Blessing JA
Cancer; 1978 Aug; 42(2):390-8. PubMed ID: 679144
[TBL] [Abstract][Full Text] [Related]
35. [The role of the structural characteristics of ovarian dysgerminoma in its prognosis].
Karseladze AI; Antoshechkina ET
Vopr Onkol; 1985; 31(4):60-6. PubMed ID: 4002671
[TBL] [Abstract][Full Text] [Related]
36. Ovarian dysgerminoma: report of seven cases and review of the literature.
Gallion HH; van Nagell JR; Donaldson ES; Powell DE
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 1):591-5. PubMed ID: 3279788
[TBL] [Abstract][Full Text] [Related]
37. Dysgerminoma of the ovary.
LaPolla JP; Benda J; Vigliotti AP; Anderson B
Obstet Gynecol; 1987 Jun; 69(6):859-64. PubMed ID: 3574816
[TBL] [Abstract][Full Text] [Related]
38. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
[TBL] [Abstract][Full Text] [Related]
39. [Clinical analysis of 57 patients with ovarian dysgerminoma].
Li YF; Li MD; Wu QL; Liu FY; Li JD; Zou JL; Huang YW
Ai Zheng; 2002 Jan; 21(1):79-82. PubMed ID: 12500404
[TBL] [Abstract][Full Text] [Related]
40. Dysgerminoma of the ovary: review of 27 cases.
Susnerwala SS; Pande SC; Shrivastava SK; Dinshaw KA
J Surg Oncol; 1991 Jan; 46(1):43-7. PubMed ID: 1986147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
